Alexandra Balcom insider trades

Open-market stock purchases and sales by Alexandra Balcom, Chief Financial Officer at Nuvalent, Inc, from SEC Form 4 filings since Jan 4, 2022.

Recent trades

DateStockTradeValue
Jul 15, 2026NUVL Nuvalent, IncSold (not open market)$5.5M
Jul 15, 2026NUVL Nuvalent, IncSold (not open market)—
Jul 15, 2026NUVL Nuvalent, IncBought (not open market)—
Jul 15, 2026NUVL Nuvalent, IncSold (not open market)—
Jul 15, 2026NUVL Nuvalent, IncSold (not open market)$142K
Jul 15, 2026NUVL Nuvalent, IncSold (not open market)$55.2K
Jul 15, 2026NUVL Nuvalent, IncSold (not open market)$434K
Jul 15, 2026NUVL Nuvalent, IncSold (not open market)$2.3M
Jul 15, 2026NUVL Nuvalent, IncSold (not open market)$2.4M
Jul 15, 2026NUVL Nuvalent, IncSold (not open market)$2.9M
Jul 15, 2026NUVL Nuvalent, IncSold (not open market)$1.9M
Jul 1, 2026NUVL Nuvalent, IncSold$1.4M
Jul 1, 2026NUVL Nuvalent, IncBought (not open market)—
Jul 1, 2026NUVL Nuvalent, IncBought (not open market)—
Jun 2, 2026CBIO Crescent Biopharma, IncBought (not open market)—
Jun 1, 2026NUVL Nuvalent, IncSold$91.1K
Jun 1, 2026NUVL Nuvalent, IncSold$208K
Jun 1, 2026NUVL Nuvalent, IncSold$313K
Jun 1, 2026NUVL Nuvalent, IncSold$260K
Jun 1, 2026NUVL Nuvalent, IncSold$20.8K
Jun 1, 2026NUVL Nuvalent, IncBought (not open market)—
Jun 1, 2026NUVL Nuvalent, IncSold$87.9K
Jun 1, 2026NUVL Nuvalent, IncSold$118K
Jun 1, 2026NUVL Nuvalent, IncSold$28.4K
May 1, 2026NUVL Nuvalent, IncBought (not open market)—

Companies traded

  • NUVL Nuvalent, Inc: 81 sales, last Jul 15, 2026
  • CBIO Crescent Biopharma, Inc: other filings, last Jun 2, 2026

Get free alerts when Alexandra Balcom files a new trade →